Search for: [Abstract = "use ofβ2\-agonist in the last year and the quality of life. Subjectiveassessment of asthma control in this period expressed by the child andthe caregiver did not affect the level of quality of life in any of thetested groups.In further analyzes, there were no statistically significant differencesbetween groups I and II in quantitative and qualitative evaluation ofphysical capacity. In addition, univariate regression showed nosignificant correlation between the quality of life of children in eachgroup and the parameters of pulmonary function tests \(FEV1, PEFR,D% FEV1, D%PEFR\), nor physical capacity determinedquantitatively \(Ww\) or qualitatively.Subsequent assessment of the relationships between different asthmasymptoms \(in the last\: week, month, year\) and quality of life ofchildren, using multivariate regression analysis, identified asimportant factors\: the frequency of asthma symptoms and thefrequency of use of β2\-agonists, but only for the period of the lastyear.In caregivers of the children in group I and group II, there were nosignificant differences in comparing their quality of life, taking intoaccount its particular domains based on the questionnaire PACQLQ\(questionnaire designed for the child's parents\).There was no significant correlation of the quality of life of parentsand child’s\: gender, age, severity level of asthma, and the level ofasthma treatment. Subsequent univ"]

Number of results: 1